Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Active mycelium group compound for treating breast cancer and preparation method thereof

A technology for breast cancer and a composition is applied in the field of preparation of the active mycelial group composition to achieve the effects of preventing and treating vascular sclerosis, improving curative effect and prolonging survival period

Inactive Publication Date: 2017-07-18
及长城
View PDF5 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0004] At present, there is a lack of a pure green and natural bioactive mycelia polysaccharide product that can treat breast cancer, has no toxic side effects, and does not have any hormone additives.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0134] A kind of active mycelium group combination with the treatment of breast cancer of the present invention, by weight percentage is composed of Poria cocos mycelium 30%, Armillaria mycelium 20%, Lentinus edodes mycelium 7%, Coprinus comatus mycelium 7%, 5% black fungus mycelium, 5% hairy mushroom mycelium, 5% wild ganoderma mycelium, 5% maitake mycelium, 4% cordyceps mycelium, 4% matsutake mycelium, Yunzhi fungus 4% filament and 4% Hericium erinaceus mycelium.

Embodiment 2

[0136] A kind of active mycelium group combination with the treatment of breast cancer of the present invention is composed of Poria cocos mycelium 26%, Armillaria mycelium 24%, Lentinus edodes mycelium 7%, Coprinus comatus mycelium 7% by weight percentage , 6% black fungus mycelium, 6% hairy mushroom mycelium, 4% wild ganoderma mycelium, 4% maitake mycelium, 5% cordyceps mycelium, 5% matsutake mycelium, versicolor versicolor Composition of 3% mycelium and 3% Hericium erinaceus mycelium.

Embodiment 3

[0138] A kind of active mycelia combination with the treatment of breast cancer of the present invention, by weight percentage is made up of Poria cocos mycelium 25%, Armillaria mycelium 20%, shiitake mushroom mycelium 6%, Coprinus comatus mycelium 6% , 7% black fungus mycelium, 7% hairy mushroom mycelium, 7% wild ganoderma mycelium, 7% maitake mycelium, 5% cordyceps mycelium, 5% matsutake mycelium, versicolor versicolor Composition of 3% mycelium and 2% Hericium erinaceus mycelium.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention relates to an active mycelium group compound for treating breast cancer and relates to a preparation method for the active mycelium group compound. The active mycelium group compound comprises the following components by weight percent: 25-30% of poria cocos mycelium, 20-24% of halimasch mycelium, 5-7% of mushroom mycelium, 5-7% of coprinus comatus mycelium, 4-6% of black fungus mycelium, 4-6% of Maojian mushroom mycelium, 4-6% of ganoderma lucidum mycelium, 4-6% of grifola frondosa mycelium, 3-5% of cordyceps sinensis mycelium, 3-5% of tricholoma matsutake mycelium, 3-5% of coriolus versicolor mycelium and 3-5% of hericium erinaceus mycelium. The active mycelium group compound is green, safe and healthy, has a function of treating breast cancer and is suitable for the patient suffering from breast cancer.

Description

technical field [0001] The invention relates to an active mycelium composition for treating breast cancer, and also relates to a preparation method of the active mycelium composition. Background technique [0002] Due to their own physiological characteristics and other reasons, women have some special health care needs. The unique and diverse drug needs of female patients determine the potential development prospects of the drug market related to women. [0003] In recent years, the incidence of breast cancer has increased dramatically. In Western countries, breast cancer has become the number one cause of death among women. In recent years, the incidence of breast cancer in my country has also been on the rise. In large cities in my country, the incidence of breast cancer has also become the No. 1 or No. 2 tumor disease among women, while in the vast rural areas, breast cancer still ranks No. 9 among tumor diseases. Breast cancer can be described as a "beauty killer" b...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): A61K36/076A61P35/00
CPCA61K9/0095A61K36/06A61K36/068A61K36/07A61K36/074A61K36/076A61K2236/19A61K2300/00
Inventor 及长城
Owner 及长城
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com